(Q43897798)

27 November 2017

Increased plasma levels of neuropeptide Y in hepatorenal syndrome (English)

1 reference

27 November 2017

2

1 reference

27 November 2017

10

1 reference

27 November 2017

12

Juan Rodés

1 reference

27 November 2017

1

Juan Uriz

1 reference

27 November 2017

6

Blas Calahorra

1 reference

27 November 2017

4

Wladimiro Jiménez

1 reference

27 November 2017

Rolando Ortega

3

1 reference

27 November 2017

Andrés Cárdenas

5

1 reference

27 November 2017

Pau Sort

7

1 reference

27 November 2017

Javier Fernández

8

1 reference

27 November 2017

Ramón Bataller

9

1 reference

27 November 2017

Francisca Rivera

11

1 reference

27 November 2017

1 March 2002

1 reference

27 November 2017

Journal of Hepatology

1 reference

27 November 2017

36

1 reference

27 November 2017

349-355

1 reference

27 November 2017

3

1 reference

27 November 2017

The hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Hepatorenal disorders: role of the sympathetic nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Sympathetic nervous activity in cirrhosis. A survey of plasma catecholamine studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Neural control of renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Peptides as neurotransmitters in vascular autonomic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Renal effects of neuropeptide Y.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Neuropeptide Y and cardiovascular regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

A new method for the determination of inulin in plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Assessment of the renin-angiotensin system in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

The nerves of the juxtaglomerular apparatus of man and other mammals contain the potent peptide NPY

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Identification of noradrenergic nerve terminals immunoreactive for neuropeptide Y and vasoactive intestinal peptide in the rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Neuropeptide (neuropeptide Y, neurotensin, vasoactive intestinal polypeptide, substance P, calcitonin gene-related peptide, somatostatin) immunohistochemistry and ultrastructure of renal nerves.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

The role of neuropeptide Y in cardiovascular regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Expression of the human neuropeptide tyrosine Y1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Effects of neuropeptide Y on the renal, mesenteric and hindlimb vascular beds of the conscious rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Renovascular effects of neuropeptide-Y in the split hydronephrotic rat kidney: non-uniform pattern of vascular reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Differential effect of neuropeptide-Y on membrane potential of cells in renal arterioles of the hydronephrotic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Vasoconstriction of rat renal interlobar arteries by noradrenaline and neuropeptide Y

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Repeated renal and splenic sympathetic nerve stimulation in anaesthetized pigs: maintained overflow of neuropeptide Y in controls but not after reserpine.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

SR 120107A antagonizes neuropeptide Y Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Pathogenesis and management of the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Neuroendocrinology of chronic renal failure and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Plasma levels of vasoactive regulatory peptides in patients receiving regular hemodialysis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Elevated plasma concentrations of neuropeptide Y in children and adults with chronic and terminal renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Increased Sympathetic Nervous Activity and the Effects of Its Inhibition with Clonidine in Alcoholic Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Noradrenaline and adrenaline concentrations in various vascular beds in patients with cirrhosis. Relation to haemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900286-0

7 January 2021

10.1016/S0168-8278(01)00286-0

Identifiers

DOI

1 reference

27 November 2017

1 reference